207527871	207527871	CD	B-NP	O
|	|	NN	I-NP	O
TTTMC	TTTMC	NN	I-NP	O
|	|	NN	I-NP	O
46079570	46079570	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0039053	0039053	CD	B-NP	O
|	|	CC	I-NP	O
6/27/2004	6/27/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
pre-syncope	pre-syncope	JJ	I-NP	O
,	,	,	I-NP	O
non-cardiac	non-cardiac	JJ	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/24/2004	2/24/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/24/2004	11/24/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
BONETTI	BONETTI	NN	B-NP	O
,	,	,	O	O
RASHAD	RASHAD	NN	B-NP	O
679-79-93-6	679-79-93-6	CD	I-NP	O
Ficonmipa	Ficonmipa	NNP	I-NP	O
Ln	Ln	NNP	I-NP	O
.	.	.	O	O

Room	Room	NNP	B-NP	O
:	:	:	O	O
Southsterter	Southsterter	NNP	B-NP	O
Tes	Tes	NNP	I-NP	O
Ter	Ter	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
6/8/04	6/8/04	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
Attending	Attend	VBG	B-VP	O
evaluation	evaluation	NN	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
PFLUGER	PFLUGER	NNP	B-NP	O
,	,	,	O	O
CARY	CARY	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
J.D.	J.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
650	650	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q4H	Q4H	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Headache	Headache	NNP	I-NP	I-protein
ALBUTEROL	ALBUTEROL	NNP	I-NP	I-protein
INHALER	INHALER	NNP	I-NP	I-protein
2	2	CD	I-NP	I-protein
PUFF	PUFF	NNP	I-NP	I-protein
INH	INH	NNP	I-NP	I-protein
QID	QID	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
6/7	6/7	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
ECASA	ECASA	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ASPIRIN	ASPIRIN	NNP	I-NP	I-protein
ENTERIC	ENTERIC	NNP	I-NP	I-protein
COATED	COATED	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
81	81	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
ATENOLOL	ATENOLOL	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LEVOXYL	LEVOXYL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
75	75	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ZOCOR	ZOCOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/3/04	3/3/04	CD	B-NP	O
by	by	IN	B-PP	O
BINGGELI	BINGGELI	NN	B-NP	O
,	,	,	O	O
LONNIE	LONNIE	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
61918195	61918195	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
ATORVASTATIN	ATORVASTATIN	NN	B-NP	B-protein
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
unknown	unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
IMDUR	IMDUR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ISOSORBIDE	ISOSORBIDE	NN	I-NP	O
MONONIT	MONONIT	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	O
SR	SR	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
ZANTAC	ZANTAC	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
RANITIDINE	RANITIDINE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
150	150	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
CELEBREX	CELEBREX	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
CELECOXIB	CELECOXIB	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
200	200	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Beeler	Beeler	NNP	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
to	to	TO	B-VP	O
call	call	VB	I-VP	O
for	for	IN	B-PP	O
appt	appt	NN	B-NP	B-protein
1-2	1-2	CD	B-NP	I-protein
weeks	week	NNS	I-NP	I-protein
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Pre-syncope	Pre-syncope	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
pre-syncope	pre-syncope	JJ	I-NP	O
,	,	,	I-NP	O
non-cardiac	non-cardiac	JJ	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
asthma	asthma	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
asthma	asthma	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
elevated	elevated	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
elevated	elevate	VBD	B-VP	O
cholesterol	cholesterol	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
varicose	varicose	NN	I-NP	I-protein
veins	vein	NNS	I-NP	I-protein
-LRB-	-LRB-	SYM	B-VP	I-protein
varicose	varicose	NN	B-NP	I-protein
veins	vein	NNS	I-NP	I-protein
-RRB-	-RRB-	VBP	B-VP	O
UTIs	UTI	NNS	B-NP	O
-LRB-	-LRB-	JJ	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
75	75	CD	B-NP	O
yo	yo	NN	I-NP	O
Spanish	Spanish	JJ	I-NP	O
speaking	speaking	NN	I-NP	O
F	F	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
HTN	HTN	NN	I-NP	B-protein
,	,	,	O	O
high	high	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
presents	present	VBZ	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	I-NP	O
pre-syncope	pre-syncope	NN	I-NP	O
.	.	.	O	O

*********	*********	SYM	O	O
Seen	Seen	NN	B-NP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	O
3d	3d	CD	I-NP	O
PTA	PTA	NN	I-NP	O
for	for	IN	B-PP	O
L	L	NN	B-NP	B-protein
hip	hip	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
HA	HA	NN	B-NP	O
,	,	,	O	O
polyarthralgias	polyarthralgia	NNS	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
then	then	RB	B-ADVP	O
showed	show	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
brady	brady	NN	I-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
noted	note	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
mildly	mildly	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
visit	visit	NN	I-NP	O
at	at	IN	B-PP	O
5.3	5.3	CD	B-NP	O
,	,	,	O	O
RF	RF	NN	B-NP	B-protein
and	and	CC	I-NP	O
ANA	ANA	NN	I-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

Now	Now	RB	B-ADVP	O
p/w	p/w	VB	B-VP	O
1-2	1-2	CD	B-NP	O
days	day	NNS	I-NP	O
presyncopal	presyncopal	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
x2	x2	CD	B-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
while	while	IN	B-SBAR	O
walking	walk	VBG	B-VP	O
then	then	RB	B-ADVP	O
this	this	DT	B-NP	O
am	am	NN	I-NP	O
at	at	IN	B-PP	O
church	church	NN	B-NP	O
while	while	IN	B-SBAR	O
seated	seat	VBN	B-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
SOB	SOB	NN	I-NP	B-protein
,	,	,	O	O
CP	CP	NN	B-NP	B-DNA
,	,	,	O	O
palps	palp	NNS	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
LOC	LOC	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
f/s/c	f/s/c	NN	I-NP	O
,	,	,	O	O
wt	wt	NN	B-NP	O
loss	loss	NN	I-NP	O
,	,	,	O	O
+	+	JJ	B-NP	O
dec	dec	NN	I-NP	O
'd	'd	MD	B-VP	O
po	po	VB	I-VP	O
's	's	POS	B-NP	O
x2	x2	NN	I-NP	O
days	day	NNS	I-NP	O
2/2	2/2	CD	B-NP	O
n/dyspepsia	n/dyspepsia	NN	I-NP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
+	+	SYM	B-VP	O
BRBPR	BRBPR	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
minimal	minimal	JJ	I-NP	O
blood	blood	NN	I-NP	O
x1-2d	x1-2d	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
chronic	chronic	JJ	B-NP	O
L	L	NN	I-NP	O
>	>	SYM	B-NP	O
R	R	NN	I-NP	O
hip	hip	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
:	:	:	O	O
afeb	afeb	NN	B-NP	O
,	,	,	O	O
normotensive	normotensive	JJ	B-NP	O
,	,	,	I-NP	O
rec	rec	NN	I-NP	O
'd	'd	MD	B-VP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-DNA
51	51	CD	I-NP	I-DNA
.	.	.	O	O

Has	Ha	NNS	B-NP	B-protein
been	be	VBN	B-VP	O
taking	take	VBG	I-VP	O
meds	med	NNS	B-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
:	:	:	O	O
98.5	98.5	CD	B-NP	O
65147/80	65147/80	CD	I-NP	O
12	12	CD	I-NP	O
99	99	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
,	,	,	O	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
mm	mm	NN	B-NP	O
dry	dry	JJ	I-NP	O
,	,	,	O	O
OP	OP	NNP	B-NP	O
clear	clear	JJ	I-NP	O
,	,	,	I-NP	O
JVP	JVP	NN	I-NP	O
flat	flat	JJ	B-ADJP	O
,	,	,	O	O
CTAB	CTAB	NN	B-NP	B-protein
,	,	,	O	O
rrr	rrr	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
m/g/r	m/g/r	NN	I-NP	O
,	,	,	O	O
ABd	ABd	NNP	B-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
NT/ND	NT/ND	NN	I-NP	B-protein
,	,	,	O	O
heme	heme	NN	B-NP	B-protein
pos	po	NNS	I-NP	I-protein
brown	brown	VBP	B-VP	O
stool	stool	NN	B-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
ext	ext	JJ	I-NP	O
hemorrhoids	hemorrhoid	NNS	I-NP	O
,	,	,	O	O
TR	TR	NN	B-NP	O
edema	edema	NN	I-NP	O
bilat	bilat	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
L	L	NN	I-NP	O
>	>	SYM	B-NP	O
R	R	NN	I-NP	O
trochanteric	trochanteric	JJ	I-NP	O
bursa	bursa	NN	I-NP	O
point	point	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
neuro	neuro	NN	B-NP	B-protein
non-focal	non-focal	JJ	I-NP	I-protein
LABS	LABS	NN	I-NP	I-protein
:	:	:	O	O
cardiac	cardiac	JJ	B-NP	O
enzymes	enzyme	NNS	I-NP	O
neg	neg	NN	I-NP	O
x1	x1	NN	I-NP	O
,	,	,	O	O
UA	UA	NNP	B-NP	O
neg	neg	NN	I-NP	O
,	,	,	O	O
TSH	TSH	NN	B-NP	B-protein
5.3	5.3	CD	I-NP	I-protein
,	,	,	O	O
otherwise	otherwise	RB	B-ADJP	O
unremarkable	unremarkable	JJ	I-ADJP	O
,	,	,	O	O
Hct	Hct	NNP	B-NP	O
40	40	CD	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

*****	*****	SYM	O	O
HOSP	HOSP	NN	B-NP	O
COURSE	COURSE	NN	I-NP	O
*******	*******	SYM	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
unlikely	unlikely	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
origin	origin	NN	I-NP	O
of	of	IN	B-PP	O
presyncope	presyncope	NN	B-NP	O
,	,	,	O	O
more	more	RBR	B-NP	O
likely	likely	JJ	I-NP	O
mild	mild	JJ	I-NP	O
hypovolemia	hypovolemia	NN	I-NP	O
.	.	.	O	O

R/R	R/R	NN	B-NP	O
:	:	:	O	O
monitored	monitor	VBN	B-VP	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
,	,	,	O	O
noted	note	VBD	B-VP	O
to	to	TO	I-VP	O
brady	brady	VB	I-VP	O
to	to	TO	B-PP	O
low	low	JJ	B-NP	O
50s	50	NNS	I-NP	O
after	after	IN	B-PP	O
ta	ta	NN	B-NP	O
king	king	NN	I-NP	O
atenolol	atenolol	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
contributing	contribute	VBG	I-NP	O
factor	factor	NN	I-NP	O
.	.	.	O	O

ISCHEMIA	ISCHEMIA	NN	B-NP	O
:	:	:	O	O
R/o	R/o	NN	B-NP	B-protein
'd	'd	MD	B-VP	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
by	by	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
.	.	.	O	O

LDL	LDL	NN	B-NP	B-protein
elevated	elevate	VBN	B-VP	O
,	,	,	O	O
vague	vague	JJ	B-NP	O
rxn	rxn	NN	I-NP	O
to	to	TO	B-PP	O
lipitor	lipitor	NN	B-NP	O
.	.	.	O	O

Started	Start	VBN	B-NP	O
zocor	zocor	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
'd	'd	NNP	I-NP	O
BB	BB	NNP	I-NP	O
,	,	,	O	O
imdur	imdur	NN	B-NP	O
.	.	.	O	O

aMIBI	aMIBI	NN	B-NP	O
6/21	6/21	CD	I-NP	O
showed	show	VBD	B-VP	O
:	:	:	O	O
small	small	JJ	B-NP	O
reversible	reversible	JJ	I-NP	O
defect	defect	NN	I-NP	O
of	of	IN	B-PP	O
mild	mild	JJ	B-NP	O
intensity	intensity	NN	I-NP	O
in	in	IN	B-PP	O
distal	distal	JJ	B-NP	O
ant	ant	JJ	I-NP	O
wall	wall	NN	I-NP	O
and	and	CC	I-NP	O
apex	apex	NN	I-NP	O
c/w	c/w	NN	I-NP	O
small	small	JJ	I-NP	O
area	area	NN	I-NP	O
ischemia	ischemia	NN	I-NP	O
in	in	IN	B-PP	O
distal	distal	JJ	B-NP	O
LAD	LAD	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
reports	report	VBZ	B-VP	O
prior	prior	JJ	B-NP	O
h/o	h/o	NN	I-NP	O
blood	blood	NN	I-NP	O
in	in	IN	B-PP	O
stool	stool	NN	B-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
ASA	ASA	NN	B-NP	O
.	.	.	O	O

Advised	Advise	VBN	B-VP	O
of	of	IN	B-PP	O
benefits	benefit	NNS	B-NP	O
of	of	IN	B-PP	O
ASA	ASA	NN	B-NP	O
for	for	IN	B-PP	O
her	her	PRP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
81mg	81mg	NN	B-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
advised	advise	VBD	B-VP	O
to	to	TO	I-VP	O
try	try	VB	I-VP	O
this	this	DT	B-NP	O
and	and	CC	O	O
discuss	discuss	VBP	B-VP	O
further	further	RBR	B-ADVP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

PUMP	PUMP	NN	B-NP	O
:	:	:	O	O
gave	give	VBD	B-VP	O
500cc	500cc	CD	B-NP	O
NS	NS	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
on	on	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

Unable	Unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
perform	perform	VB	I-VP	O
echo	echo	RB	B-ADJP	O
prior	prior	JJ	I-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
but	but	CC	O	O
may	may	MD	B-VP	O
pursue	pursue	VB	I-VP	O
this	this	DT	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
noted	note	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypertensive	hypertensive	JJ	B-ADJP	O
to	to	TO	B-PP	O
180	180	CD	B-NP	O
SBP	SBP	NN	I-NP	O
20-24h	20-24h	NN	I-NP	O
after	after	IN	B-PP	O
atenolol	atenolol	NN	B-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
switched	switch	VBN	B-VP	O
to	to	TO	I-VP	O
bid	bid	VB	I-VP	O
frequency	frequency	NN	B-NP	O
with	with	IN	B-PP	O
1/2	1/2	CD	B-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
25mg	25mg	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-VP	I-protein
given	give	VBN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
.	.	.	O	O

May	May	NNP	B-NP	O
consider	consider	VB	B-VP	O
increasing	increase	VBG	B-NP	O
imdur	imdur	NN	I-NP	O
if	if	IN	B-SBAR	O
persistent	persistent	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
dyspepsia	dyspepsia	NN	B-NP	O
.	.	.	O	O

Started	Started	NNP	B-NP	O
PPI	PPI	NNP	I-NP	O
,	,	,	O	O
chk	chk	NN	B-NP	O
'd	'd	NNP	I-NP	O
H.pylori	H.pylori	NNP	I-NP	O
.	.	.	O	O

May	May	MD	O	O
benefit	benefit	NN	B-NP	O
from	from	IN	B-PP	O
EGD	EGD	NN	B-NP	B-protein
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

D/c	D/c	NN	B-NP	O
'd	'd	VBD	B-VP	O
on	on	IN	B-PP	O
H2	H2	NN	B-NP	O
blker	blker	NN	I-NP	O
ENDO	ENDO	NN	I-NP	O
:	:	:	O	O
mildly	mildly	RB	B-ADJP	O
subtherapeutic	subtherapeutic	JJ	I-ADJP	O
on	on	IN	B-PP	O
levoxyl	levoxyl	NN	B-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
to	to	TO	I-VP	O
75mcg	75mcg	VB	I-VP	O
qd	qd	NN	B-NP	O
MSK	MSK	NN	I-NP	O
:	:	:	O	O
trochanteric	trochanteric	JJ	B-NP	O
bursitis	bursitis	NN	I-NP	O
.	.	.	O	O

Rx	Rx	NN	B-NP	B-protein
'd	'd	MD	B-VP	O
w	w	VB	I-VP	O
/	/	SYM	B-NP	O
NSAIDS	NSAIDS	NN	I-NP	O
,	,	,	O	O
d/c	d/c	NN	B-NP	O
'd	'd	VBD	B-VP	O
on	on	IN	B-PP	O
celebrex	celebrex	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
may	may	MD	B-VP	O
consider	consider	VB	I-VP	O
changing	change	VBG	I-VP	O
to	to	TO	I-VP	O
hi	hi	VB	I-VP	O
dose	dose	NN	B-NP	O
ibuprofen	ibuprofen	NN	I-NP	O
PULM	PULM	NN	I-NP	O
:	:	:	O	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
cont	cont	NN	B-NP	O
'd	'd	MD	B-VP	O
albuterol	albuterol	VB	I-VP	O
inh	inh	NN	B-NP	O
prn	prn	NN	I-NP	O
PPX	PPX	NN	I-NP	O
:	:	:	O	O
lovenox	lovenox	NN	B-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
ppx	ppx	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
you	you	PRP	B-NP	O
call	call	VBP	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Mcquade	Mcquade	NNP	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
follow	follow	NN	I-NP	O
up	up	RP	B-PRT	O
appointment	appointment	NN	B-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	B-protein
1-2	1-2	CD	I-NP	I-protein
weeks	week	NNS	I-NP	I-protein
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
take	take	VB	I-VP	O
all	all	DT	B-NP	O
medications	medication	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
discharge	discharge	NN	I-NP	O
list	list	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
doses	dose	NNS	I-NP	O
specified	specify	VBN	B-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
you	you	PRP	B-NP	O
stay	stay	VBP	B-VP	O
well	well	RB	I-VP	O
hydrated	hydrate	VBN	I-VP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
feel	feel	VBP	B-VP	O
lightheaded	lightheade	VBN	B-ADJP	O
,	,	,	O	O
fall	fall	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
lose	lose	NN	B-NP	O
consciousness	consciousness	NN	I-NP	O
,	,	,	O	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
or	or	CC	O	O
seek	seek	VB	B-VP	O
attention	attention	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
nearest	near	JJS	I-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
CASTILLIO	CASTILLIO	NNP	B-NP	O
,	,	,	O	O
GLENN	GLENN	NNP	B-NP	O
QUINTON	QUINTON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AM310	AM310	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6/8/04	6/8/04	CD	I-NP	O
@	@	SYM	B-NP	O
04	04	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

